ABSTRACT
A number of neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by intraneuronal accumulation of the tau protein. Some forms of FTDP-17 are caused by mutations in the tau gene affecting exon 10 splicing. Therefore, dysregulation of tau pre-mRNA splicing may be a contributing factor to sporadic tauopathies. To address this question, we devised a real-time RT-PCR strategy based on the use of a single fluorogenic probe to evaluate the ratio between tau isoforms containing or lacking exon 10 (4R/3R ratio) in post-mortem brain samples. We found a two- to six-fold increase in the 4R/3R ratio in cases of FTDP-17 linked to a splice site mutation, hence confirming the validity of the strategy. The difference in the 4R/3R ratio in the superior temporal and superior frontal gyri between AD and control brains was not statistically significant. Similarly, there was no significant difference in the 4R/3R ratio between Pick's disease cases and controls, indicating that the predominance of tau3R protein in PiD reflects post-translational modifications of specific isoforms. This study indicates that post-translational events are likely to be the main factors controlling tau isoform composition in sporadic tauopathies and highlights the benefit of quantitative RT-PCR in the assessment of splicing abnormalities in tauopathies.
Subject(s)
Alternative Splicing/genetics , Brain/metabolism , Mutation/genetics , Polymorphism, Genetic/genetics , Tauopathies/genetics , tau Proteins/genetics , Aged , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Base Sequence/genetics , Brain/pathology , Brain/physiopathology , Dementia/genetics , Dementia/metabolism , Dementia/physiopathology , Exons/genetics , Humans , Middle Aged , Molecular Sequence Data , Pick Disease of the Brain/genetics , Pick Disease of the Brain/metabolism , Pick Disease of the Brain/physiopathology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Processing, Post-Translational/genetics , RNA Splice Sites/genetics , RNA, Messenger/analysis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Tauopathies/metabolism , Tauopathies/physiopathology , tau Proteins/metabolismABSTRACT
We found previously that aggregated insoluble tau protein in progressive supranuclear palsy (PSP) brains exhibits a heterogeneous pattern that is not segregated by the type of clinical presentation. Here we have investigated tau isoform composition from 20 PSP cases and found marked variation between different brains. Cases were classified into three groups, each comprising essentially of (1) 1N4R; (2) 1N4R and 1N3R; or (3) 1N4R, 1N3R and 0N4R tau isoforms. There was also an absence of a simple relationship between isoform composition and the pattern of insoluble tau before dephosphorylation. We conclude that there is distinct molecular heterogeneity in the involvement of tau isoforms in the tau pathology in PSP.
Subject(s)
Protein Isoforms/metabolism , Supranuclear Palsy, Progressive/metabolism , tau Proteins/metabolism , Aged , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Blotting, Western/methods , Brain Chemistry , Female , Humans , Male , Middle Aged , Phosphorylation , Recombinant Proteins/metabolism , Supranuclear Palsy, Progressive/physiopathologyABSTRACT
Pathological inclusions containing fibrillar aggregates of hyperphosphorylated tau protein are a characteristic feature in the tauopathies, which include Alzheimer's disease, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Tau isoform composition and cellular and regional distribution as well as morphology of these inclusions vary in each disorder. Recently, several pathological missense and exon 10 splice-donor site mutations of the tau gene were identified in FTDP-17. Exon 10 codes for the second of four microtubule-binding repeat domains. The splice-site mutations result in increased inclusion of exon 10 which causes a relative increase in tau isoforms containing four microtubule-binding repeat domains over those containing three repeat domains. This could be a central aetiological mechanism in FTDP-17 and, perhaps, other related tauopathies. We have investigated changes in the ratio and distribution of three-repeat and four-repeat tau in the different tauopathies as a basis of the phenotypic range of these disorders and the selective vulnerability of different subsets of neurones. In this study, we have developed two monoclonal antibodies, RD3 and RD4 that effectively distinguish these closely related tau isoforms. These new isoform-specific antibodies are useful tools for analysing tau isoform expression and distribution as well as pathological changes in the human brain.
Subject(s)
Antibodies, Monoclonal , Antibody Specificity , Brain/pathology , Tauopathies/immunology , tau Proteins/analysis , tau Proteins/immunology , Animals , Blotting, Western , Brain/metabolism , Brain/ultrastructure , Cell Line , Humans , Immunohistochemistry , Inclusion Bodies/metabolism , Inclusion Bodies/pathology , Inclusion Bodies/ultrastructure , Microscopy, Immunoelectron , Microtubules/chemistry , Neuroblastoma/chemistry , Neuroblastoma/genetics , Neurofibrillary Tangles/chemistry , Neurons/metabolism , Neurons/pathology , Protein Isoforms/biosynthesis , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/immunology , Rats , Recombinant Proteins , Tauopathies/genetics , Tauopathies/metabolism , Tauopathies/pathology , tau Proteins/biosynthesis , tau Proteins/geneticsABSTRACT
Phosphorylated tau is deposited as insoluble inclusion bodies in the tauopathies. We have used a new efficient method to dephosphorylate tau extracted from control and tauopathy brain. In some tauopathies, including Alzheimer's disease and progressive supranuclear palsy, the pattern of insoluble tau isoforms reflected that of soluble tau. In contrast, in corticobasal degeneration, Pick's disease, and some forms of fronto-temporal dementia, specific tau isoforms were selectively sequestered into insoluble inclusion-forming tau. Therefore the overall expression of individual tau isoforms does not predict which tau isoforms are deposited in all tauopathies and different mechanisms must operate that result in the deposition of specific tau isoforms.
Subject(s)
Brain Diseases/metabolism , Protein Isoforms/metabolism , tau Proteins/metabolism , Amino Acid Sequence , Blotting, Western , Brain/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Molecular Sequence Data , Phosphorylation , SolubilityABSTRACT
We have identified two groups of patients with clinically typical and atypical, pathologically diagnosed progressive supranuclear palsy (PSP), and investigated their genetic and molecular pathological characteristics. Those with clinically typical PSP are more likely to have the PSP susceptibility genotype and to have the deposition of PSP-type hyperphosphorylated tau protein. The clinically atypical PSP group contains a number of different clinical syndromes, including an L-dopa unresponsive bradykinetic syndrome and a clinical syndrome closely resembling idiopathic Parkinson's disease. The clinically atypical PSP group are less likely to have the PSP susceptibility genotype and often have the deposition of Alzheimer's disease paired helical filament type hyperphosphorylated tau. This study suggests that the tau PSP susceptibility genotype is most strongly associated with clinically typical PSP. Neurofibrillary tangle parkinsonian disorders, which pathologically resemble PSP but involve the deposition of Alzheimer's disease-type tau often without involvement of the tau susceptibility genotype, need to be distinguished for diagnostic and research purposes.
Subject(s)
Genetic Heterogeneity , Supranuclear Palsy, Progressive/genetics , Supranuclear Palsy, Progressive/pathology , Aged , Aged, 80 and over , Brain/pathology , Humans , Middle Aged , tau Proteins/geneticsABSTRACT
Healthy, sedentary, college-age subjects (n = 16) performed concentric or eccentric maximal unilateral isokinetic (1.08 rad s(-1)) elbow flexor contractions (4 sets of 12 repetitions) to fatigue as physiological data were concurrently collected. Net caloric expenditure was determined using indirect calorimetry, whereas the electromyogram examined root mean square (RMS) and mean power frequency (MPF) values for the biceps brachii, brachioradialis, and palmaris longus. Eccentric exercise resulted in significantly greater (p < 0.05) absolute (total work per kilocalorie) and relative (total work per kilocalorie per kilogram) exercise efficiency values. Concentric biceps brachii and brachioradialis RMS values were significantly (p < 0.05) greater than corresponding eccentric values, suggesting greater motor unit recruitment. Concentric MPF values, a measure of motor unit fatigue, showed significantly (p < 0.05) greater before and after decrements following exercise for the biceps brachii and brachioradialis. Greater exercise efficiency with less motor unit recruitment and fatigue results from eccentric exercise.
Subject(s)
Elbow/physiology , Exercise/physiology , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Adolescent , Adult , Analysis of Variance , Electromyography , Energy Metabolism , Female , Humans , Isometric Contraction/physiology , Male , Muscle Fatigue , Muscle, Skeletal/innervation , Tensile Strength/physiologyABSTRACT
The finding that APOE (the gene encoding apolipoprotein E) polymorphic variation was associated with an altered risk of developing Alzheimer's disease (AD) was a significant advance and immediately prompted a search for the mechanisms responsible for this alteration. Some 6 years later, a number of different hypotheses remain that might account for this influence on pathogenesis with no single mechanism being unequivocally accepted. The different approaches to understanding these mechanisms can be broadly categorized as: those suggesting a remote effect, such as different rates of vascular risk factors in those with the different APOE alleles; those proposing altered neuronal vulnerability, perhaps due to apolipoprotein E (ApoE)-isoform-specific differences in local cholesterol transport; and those hypotheses postulating an ApoE interaction with the two key lesions of AD, plaques and tangles. In this chapter we will review the evidence for and against an interaction between ApoE and the neuronal cytoskeleton, in particular with the microtubule-associated protein tau.
Subject(s)
Alzheimer Disease/etiology , Alzheimer Disease/genetics , Apolipoproteins E/genetics , tau Proteins/physiology , Alleles , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Animals , Apolipoproteins E/pharmacology , Cells, Cultured , Cytoskeleton/pathology , Microtubules/drug effects , Microtubules/metabolism , Models, Neurological , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , PhosphorylationABSTRACT
The microtubule-associated protein, tau, is the principal component of paired helical filaments (PHFs) in Alzheimer's disease. PHF-tau is highly phosphorylated and a total of 25 sites of phosphorylation have so far been identified. Many of these sites are serine or threonine residues that are immediately followed in the sequence by proline residues, and hence are candidate phosphorylation sites for proline-directed kinases. In vitro, glycogen synthase kinase-3 (GSK-3), extracellular signal-related kinase-1 and -2, and mitogen-activated protein kinases, p38 kinase and c-jun N-terminal kinase, all phosphorylate many of these sites, although with different efficiencies for particular sites. Phosphorylation studies in transfected cells and neurons show that GSK-3 phosphorylates tau more extensively than do these other proline-directed kinases. Mutations in tau have been shown to affect in vitro phosphorylation of tau by GSK-3. The Arg406-->Trp (R406W) tau mutation also affects tau phosphorylation in cells.
Subject(s)
tau Proteins/metabolism , Alzheimer Disease/metabolism , Amino Acid Sequence , Animals , Binding Sites , COS Cells , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Humans , In Vitro Techniques , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 10 , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , Mutation , Neurons/metabolism , Phosphorylation , Protein-Tyrosine Kinases/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection , p38 Mitogen-Activated Protein Kinases , tau Proteins/chemistry , tau Proteins/geneticsABSTRACT
We report functional differences between tau isoforms with 3 or 4 C-terminal repeats and a difference in susceptibility to oxidative conditions, with respect to the regulation of microtubule dynamics in vitro and tau-microtubule binding in cultured cells. In the presence of dithiothreitol in vitro, a 3-repeat tau isoform promotes microtubule nucleation, reduces the tubulin critical concentration for microtubule assembly, and suppresses dynamic instability. Under non-reducing conditions, threshold concentrations of 3-repeat tau and tubulin exist below which this isoform still promotes microtubule nucleation and assembly but fails to reduce the tubulin critical concentration or suppress dynamic instability; above these threshold concentrations, amorphous aggregates of 3-repeat tau and tubulin can be produced at the expense of microtubule formation. A 4-repeat tau isoform is less sensitive to the oxidative potential of the environment, behaving under oxidative conditions similarly to the 3-repeat isoform under reducing conditions. Under conditions of oxidative stress, in Chinese hamster ovary cells stably expressing either 3- or 4-repeat tau, 3-repeat tau disassociates from microtubules more readily than the 4-repeat isoform, and tau-containing high molecular weight aggregates are preferentially observed in lysates from the Chinese hamster ovary cells expressing 3-repeat tau, indicating greater susceptibility of 3-repeat tau to oxidative conditions, compared with 4-repeat tau in vivo.
Subject(s)
Oxidative Stress , tau Proteins/chemistry , tau Proteins/physiology , Animals , CHO Cells , Cell Division , Cells, Cultured , Cricetinae , Dose-Response Relationship, Drug , Microscopy, Electron , Microscopy, Fluorescence , Microtubules/chemistry , Microtubules/metabolism , Neurons/metabolism , Protein Isoforms , Protein Structure, Tertiary , Recombinant Proteins/metabolism , Reducing Agents/pharmacology , Swine , Time Factors , TransfectionABSTRACT
Alzheimer's disease (AD) is a disorder of two pathologies: amyloid plaques, the core of which is a peptide derived from the amyloid precursor protein (APP), and neurofibrillary tangles composed of highly phosphorylated tau. Protein kinase C (PKC) is known to increase non-amyloidogenic alpha-secretase cleavage of APP, producing secreted APP (sAPPalpha), and glycogen synthase kinase (GSK)-3beta is known to increase tau phosphorylation. Both PKC and GSK-3beta are components of the wnt signaling cascade. Here we demonstrate that overexpression of another member of this pathway, dishevelled (dvl-1), increases sAPPalpha production. The dishevelled action on APP is mediated via both c-jun terminal kinase (JNK) and protein kinase C (PKC)/mitogen-activated protein (MAP) kinase but not via p38 MAP kinase. These data position dvl-1 upstream of both PKC and JNK, thereby explaining the previously observed dual signaling action of dvl-1. Furthermore, we show that human dvl-1 and wnt-1 also reduce the phosphorylation of tau by GSK-3beta. Therefore, both APP metabolism and tau phosphorylation are potentially linked through wnt signaling.
Subject(s)
Amyloid beta-Protein Precursor/metabolism , Mitogen-Activated Protein Kinases/metabolism , Phosphoproteins/metabolism , Protein Kinase C/metabolism , Zebrafish Proteins , Adaptor Proteins, Signal Transducing , Alzheimer Disease/metabolism , Amyloid Precursor Protein Secretases , Amyloid beta-Protein Precursor/genetics , Aspartic Acid Endopeptidases , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Dishevelled Proteins , Endopeptidases/metabolism , Gene Expression , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Humans , JNK Mitogen-Activated Protein Kinases , Kidney/cytology , Kidney/drug effects , Kidney/metabolism , Mutation , Phosphoproteins/genetics , Phosphoproteins/pharmacology , Phosphorylation/drug effects , Proteins/genetics , Proteins/metabolism , Proteins/pharmacology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins/pharmacology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Recombinant Fusion Proteins/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , Transfection , Wnt Proteins , Wnt1 Protein , tau Proteins/genetics , tau Proteins/metabolismABSTRACT
In vitro phosphorylation of recombinant wild-type 2N4R tau and FTDP-17 exonic mutant forms P301L, V337M and R406W by glycogen synthase kinase 3beta (GSK3beta) was examined by two dimensional phosphopeptide mapping analysis on thin layer cellulose plates. Comparison of these peptide maps with those generated from wild-type 1N4R tau isoform from which the phosphopeptide constituents and sites of phosphorylation had been determined previously, enabled us to monitor directly changes in phosphorylation of the individual tau proteins. No differences were found in the phosphorylation of wild-type, P301L or V337M tau by GSK3beta but the R406W mutant showed at least two clear differences from the other three tau proteins. The peptides, identified by mass spectrometry corresponding to phosphorylation at both threonine 231 and serine 235 (spot 3), serines 396, 400 and 404 (spot 6a) and serines 195 and 199 (spot 6b) were absent from the R406W peptide map. The findings imply that the R406W mutation in tau exerts long-range conformational effects on the structure of tau.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Microtubule-Associated Proteins/genetics , Mutation , tau Proteins/chemistry , tau Proteins/genetics , Electrophoresis, Gel, Two-Dimensional , Exons , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Humans , Mass Spectrometry , Microtubule-Associated Proteins/chemistry , Microtubule-Associated Proteins/metabolism , Mutation, Missense , Peptide Mapping , Phosphorylation/drug effects , Protein Conformation , Protein Isoforms , Protein Structure, Tertiary , Recombinant Proteins/metabolism , Spectrometry, Mass, Electrospray Ionization , tau Proteins/metabolismABSTRACT
Familial British dementia (FBD), pathologically characterized by cerebral amyloid angiopathy (CAA), amyloid plaques, and neurofibrillary degeneration, is associated with a stop codon mutation in the BRI gene resulting in the production of an amyloidogenic fragment, amyloid-Bri (ABri). The aim of this study was to assess the distribution of ABri fibrillar and nonfibrillar lesions and their relationship to neurofibrillary pathology, astroglial and microglial response using immunohistochemistry, confocal microscopy, and immunoelectron microscopy in five cases of FBD. Abnormal tau was studied with immunoblotting. We present evidence that ABri is deposited throughout the central nervous system in blood vessels and parenchyma where both amyloid (fibrillar) and pre-amyloid (nonfibrillar) lesions are formed. Ultrastructurally amyloid lesions appear as bundles of fibrils recognized by an antibody raised against ABri, whereas Thioflavin S-negative diffuse deposits consist of amorphous electron-dense material with sparse, dispersed fibrils. In contrast to nonfibrillar lesions, fibrillar ABri is associated with a marked astrocytic and microglial response. Neurofibrillary tangles and neuropil threads occurring mainly in limbic structures, are found in areas affected by all types of ABri lesions whereas abnormal neurites are present around amyloid lesions. Immunoblotting for tau revealed a triplet electrophoretic migration pattern. Our observations confirm a close link between ABri deposition and neurodegeneration in FBD.
Subject(s)
Amyloid/metabolism , Central Nervous System/chemistry , Heredodegenerative Disorders, Nervous System/metabolism , Peptide Fragments/metabolism , Adaptor Proteins, Signal Transducing , Amyloid/immunology , Antibodies, Monoclonal/analysis , Antibodies, Monoclonal/immunology , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Benzothiazoles , Blood Vessels/chemistry , Blood Vessels/pathology , Central Nervous System/pathology , Central Nervous System/ultrastructure , Congo Red , Glial Fibrillary Acidic Protein/analysis , Heredodegenerative Disorders, Nervous System/pathology , Humans , Immunoblotting , Immunohistochemistry/methods , Membrane Glycoproteins , Membrane Proteins , Microscopy, Immunoelectron , Peptide Fragments/immunology , Staining and Labeling/methods , Thiazoles , tau Proteins/analysisABSTRACT
Two hereditary conditions, familial British dementia (FBD) and familial Danish dementia (FDD), are associated with amyloid deposition in the central nervous system and neurodegeneration. The two amyloid proteins, ABri and ADan, are degradation products of the same precursor molecule BriPP bearing different genetic defects, namely a Stop-to-Arg mutation in FBD and a ten-nucleotide duplication-insertion immediately before the stop codon in FDD. Both de novo created amyloid peptides have the same length (34 amino acids) and the same post-translational modification (pyroglutamate) at their N-terminus. Neurofibrillary tangles containing the classical paired helical filaments as well as neuritic components in many instances co-localize with the amyloid deposits. In both disorders, the pattern of hyperphosphorylated tau immunoreactivity is almost indistinguishable from that seen in Alzheimer's disease. These issues argue for the primary importance of the amyloid deposits in the mechanism(s) of neuronal cell loss. We propose FBD and FDD, the chromosome 13 dementia syndromes, as models to study the molecular basis of neurofibrillary degeneration, cell death and amyloid formation in the brain.
Subject(s)
Chromosomes, Human, Pair 13/genetics , Dementia/genetics , Heredodegenerative Disorders, Nervous System/genetics , Amino Acid Sequence , Amyloid/genetics , Amyloid/metabolism , Dementia/metabolism , Dementia/pathology , Denmark , Heredodegenerative Disorders, Nervous System/metabolism , Heredodegenerative Disorders, Nervous System/pathology , Humans , Models, Genetic , Models, Neurological , Molecular Sequence Data , Mutation , Neurofibrillary Tangles/metabolism , Neurofibrillary Tangles/pathology , Syndrome , United KingdomABSTRACT
Previously published data have shown an allele-specific variation in the in vitro binding of apolipoprotein E (apoE) to tau, which prompted the hypothesis that apoE binding may protect tau from phosphorylation, apoE3 being more efficient than apoE4. We have, therefore, investigated the effects of apoE on tau phosphorylation in vitro by the proline-directed kinase, glycogen synthase kinase (GSK)-3 beta. The phosphopeptide maps of tau alone, of tau with apoE3 and of tau with apoE4 were very similar. When apoE2 was present a further four spots were evident. Additionally, of the 15 peptides phosphorylated in the presence or absence of apoE, subtle differences, some isoform-specific, in the relative amounts of phosphorylation were observed.
Subject(s)
Apolipoproteins E/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Spectrometry, Mass, Electrospray Ionization , tau Proteins/metabolism , Apolipoprotein E2 , Apolipoprotein E3 , Apolipoprotein E4 , Apolipoproteins E/genetics , Glycogen Synthase Kinases , Humans , Peptide Mapping , Phosphoproteins/chemistry , Phosphorylation , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Transfection , tau Proteins/chemistry , tau Proteins/geneticsABSTRACT
Tau was originally isolated from brain microtubules and shown to be a microtubule-associated protein (MAP) that promoted tubulin polymerization (1). It is largely confined to axons, where it is the major MAP. It promotes microtubule nucleation, elongation, and bundling, and stabilizes microtubules by inhibiting depolymerization.
ABSTRACT
Neurofibrillary tangles, one of the major pathological hallmarks of Alzheimer-diseased brains, consist primarily of aggregated paired helical filaments (PHFs) of hyperphosphorylated tau protein. Tau from normal brain and especially from foetal brain is also phosphorylated on some of the sites phosphorylated in PHFs, mainly at serines or threonines followed by prolines. A number of protein kinases can phosphorylate tau in vitro; those that require or accept prolines include GSK3 and members of the mitogen-activated protein (MAP) kinase family, ERK1, ERK2, and SAP kinase-beta/JNK. In this report, we show that another member of the MAP kinase family, the stress-activated kinase p38/RK, can phosphorylate tau in vitro. Western blots with phosphorylation-sensitive antibodies showed that p38, like ERK2 and SAP kinase-beta/JNK, phosphorylated tau at sites found phosphorylated physiologically (Thr181, Ser202, Thr205, and Ser396) and also at Ser422, which is phosphorylated in neurofibrillary tangles but not in normal adult or foetal brain. These findings support the possibility that cellular stress might contribute to tau hyperphosphorylation during the formation of PHFs, and hence, to the development of tau pathology.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Mitogen-Activated Protein Kinases , tau Proteins/metabolism , Alzheimer Disease/metabolism , Amino Acids/metabolism , Antibody Specificity , Brain Chemistry/physiology , Humans , Neurons/chemistry , Neurons/cytology , Neurons/enzymology , Phosphorylation , Stress, Physiological/metabolism , p38 Mitogen-Activated Protein Kinases , tau Proteins/immunologyABSTRACT
To study the effects of phosphorylation by glycogen synthase kinase-3beta (GSK-3beta) on the ability of the microtubule-associated protein tau to promote microtubule self-assembly, tau isoform 1 (foetal tau) and three mutant forms of this tau isoform were investigated. The three mutant forms of tau had the following serine residues, known to be phosphorylated by GSK-3, replaced with alanine residues so as to preclude their phosphorylation: (1) Ser-199 and Ser-202 (Ser-199/202-->Ala), (2) Ser-235 (Ser-235-->Ala) and (3) Ser-396 and Ser-404 (Ser-396/404-->Ala). Wild-type tau and the mutant forms of tau were phosphorylated with GSK-3beta, and their ability to promote microtubule self-assembly was compared with the corresponding non-phosphorylated tau species. In the non-phosphorylated form, wild-type tau and all of the mutants affected the mean microtubule length and number concentrations of assembled microtubules in a manner consistant with enhanced microtubule nucleation. Phosphorylation of these tau species with GSK-3beta consistently reduced the ability of a given tau species to promote microtubule self-assembly, although the affinity of the tau for the microtubules was not greatly affected by phosphorylation since the tau species remained largely associated with the microtubules. This suggests that the regulation of microtubule assembly can be controlled by phosphorylation of tau at sites accessible to GSK-3beta by a mechanism that does not necessarily involve the dissociation of tau from the microtubules.
Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Microtubules/metabolism , Protein Processing, Post-Translational , tau Proteins/metabolism , Alzheimer Disease/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Escherichia coli/metabolism , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Mutagenesis, Site-Directed , Nucleopolyhedroviruses/genetics , Phosphorylation , Recombinant Fusion Proteins/metabolism , Spodoptera/cytologyABSTRACT
A proportion of the neuronal microtubule-associated protein (MAP) tau is highly phosphorylated in foetal and adult brain, whereas the majority of tau in the neurofibrillary tangles of Alzheimer's patients is hyperphosphorylated; many of the phosphorylation sites are serines or threonines followed by prolines. Several kinases phosphorylate tau at such sites in vitro. We have now shown that purified recombinant stress-activated protein kinase/c-Jun N-terminal kinase, a proline-directed kinase of the MAP kinase extended family, phosphorylates recombinant tau in vitro on threonine and serine residues. Western blots using antibodies to phosphorylation-dependent tau epitopes demonstrated that phosphorylation occurs in both of the main phosphorylated regions of tau protein. Unlike glycogen synthase kinase-3, the c-Jun N-terminal kinase readily phosphorylates Thr205 and Ser422, which are more highly phosphorylated in Alzheimer tau than in foetal or adult tau. Glycogen synthase kinase-3 may preferentially phosphorylate the sites found physiologically, in foetal and to a smaller extent in adult tau, whereas stress-activated/c-Jun N-terminal kinase and/or other members of the extended MAP kinase family may be responsible for pathological proline-directed phosphorylations. Inflammatory processes in Alzheimer brain might therefore contribute directly to the pathological formation of the hyperphosphorylated tau found in neurofibrillary tangles.
Subject(s)
JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinase Kinases , Protein Kinase C/metabolism , Protein Kinases/metabolism , Stress, Physiological/metabolism , tau Proteins/metabolism , Antibody Specificity , Blotting, Western , Brain Chemistry/physiology , Cyclic AMP-Dependent Protein Kinases/metabolism , Epitopes/metabolism , Humans , MAP Kinase Kinase 4 , Phosphoproteins/analysis , Phosphoproteins/immunology , Phosphorylation , Serine/metabolism , Threonine/metabolism , tau Proteins/analysis , tau Proteins/immunologyABSTRACT
The two pathological lesions found in the brains of Alzheimer's disease patients, neurofibrillary tangles and neuritic plaques, are likely to be formed through a common pathway. Neurofibrillary tangles are intracellular aggregates of paired helical filaments, the main component of which is hyperphosphorylated forms of the microtubule-associated protein tau. Extracellular neuritic plaques and diffuse and vascular amyloid deposits are aggregates of beta-amyloid protein, a 4-kDa protein derived from the amyloid precursor protein (APP). Using conditions in vitro under which two proline-directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen-activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt. The sole site of phosphorylation in APPcyt by GSK-3beta was determined by phosphoamino acid analysis and phosphorylation of APPcyt mutant peptides to be Thr743 (numbering as for APP770). This site was confirmed by endoproteinase Glu-C digestion of APPcyt and peptide sequencing. The ability of GSK-3beta to phosphorylate APPcyt and tau provides a putative link between the two lesions and indicates a critical role of GSK-3beta in the pathogenesis of Alzheimer's disease.
Subject(s)
Amyloid beta-Protein Precursor/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cytoplasm/metabolism , DNA Primers/chemistry , Glycogen Synthase Kinase 3 , Glycogen Synthase Kinases , Humans , Mitogen-Activated Protein Kinase 1 , Molecular Sequence Data , Phosphorylation , Phosphothreonine/metabolism , Protein-Tyrosine Kinases/metabolism , RatsABSTRACT
BACKGROUND: Since the development of fine-needle aspiration (FNA) there has been a trend away from frozen sections (FS) in the assessment of thyroid neoplasms. The objective of this study was to determine the role of FS in the surgical management of thyroid nodules in the presence of an adequate FNA biopsy finding. METHODS: Charts of patients who presented within a 3-year period for thyroid surgery were reviewed. Inclusion criteria consisted of both an adequate FNA and FS. RESULTS: Eighty-five patients met the inclusion criteria. Three lesions were benign, 71 were suspicious, and 11 were malignant with FNA. There were 66 deferred and 19 malignant diagnoses with FS. The overall accuracy for FNA and FS was 40% and 86%, respectively. When the FNA report was positive for malignancy, it was correct in 91% (10 of 11) of the cases. When the FNA report was suspicious, only 30% (21 of 71) had a malignant lesions. FS confirmed malignancy in 19 patients and deferred more extensive surgery in 66 patients with suspicious lesions. However, 18% of the deferred FS were found to be malignant on final pathology report. CONCLUSIONS: This study showed that there is a role for FS in the surgical management of thyroid nodules. Frozen sections can be useful when the FNA report is suspicious for malignancy; however, FS may be eliminated when the FNA report is positive for malignancy.